Back
Arcosa, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Buy
79
ACA
Arcosa, Inc.
Last Price:
$109.66
Seasonality Move:
4.41%
Sell
44
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$111.76
Seasonality Move:
-13.08%
Buy
79
Arcosa, Inc. (ACA)
is a Buy
Is Arcosa, Inc. a Buy, Sell or Hold?
-
The current Arcosa, Inc. [ACA] share price is $109.68. The Score for ACA is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
-
ACA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Sell
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.73. The Score for RYTM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACA Stock Price Chart
What is Arcosa, Inc.'s stock price today?
-
The Arcosa, Inc. share price today is $109.68Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACA is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $111.73Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.
ACA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.69 | Buy |
| Relative Strength Index (14 RSI): | 62.37 | Buy |
| Chaikin Money Flow: | 167752 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.68 - 109.9) | Buy |
| Bollinger Bands (100): | (91.01 - 103.81) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.8 | Buy |
| Relative Strength Index (14 RSI): | 56.8 | Buy |
| Chaikin Money Flow: | 32783 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.63 - 111.03) | Buy |
| Bollinger Bands (100): | (95.29 - 108.53) | Buy |
ACA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.05 | Sell |
| 20-day SMA: | 107.32 | Buy |
| 50-day SMA: | 100.57 | Buy |
| 200-day SMA: | 90.86 | Buy |
| 8-day EMA: | 109.3 | Buy |
| 20-day EMA: | 107.13 | Buy |
| 50-day EMA: | 102.55 | Buy |
| 200-day EMA: | 94.95 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.65 | Buy |
| 20-day SMA: | 107.3 | Buy |
| 50-day SMA: | 106.17 | Buy |
| 200-day SMA: | 82.91 | Buy |
| 8-day EMA: | 44.16 | Buy |
| 20-day EMA: | 20.28 | Buy |
| 50-day EMA: | 8.6 | Buy |
| 200-day EMA: | 2.21 | Buy |
Arcosa, Inc. Earnings Growth & ACA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.97 per share, and an increase next year of $0.61 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.
Arcosa, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||